Paradigm Biocapital Advisors LP - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$7,006,000
+24.1%
148,216
+96.3%
1.40%
-13.3%
Q4 2021$5,646,00075,5071.61%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,546,097$66,590,0009.91%
RA Capital Management 1,539,586$66,310,0006.70%
SENZAR ASSET MANAGEMENT, LLC 255,128$10,988,0004.20%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 158,315$6,819,0001.56%
Sarissa Capital Management LP 105,000$4,522,0001.54%
Ghost Tree Capital, LLC 50,000$2,154,0001.52%
BENNETT LAWRENCE MANAGEMENT L L C/NY 118,445$5,102,0000.90%
WALL STREET ASSOCIATES 219,200$9,441,0000.81%
Granite Point Capital Management, L.P. 25,000$1,077,0000.74%
BAILARD, INC. 91,500$3,941,0000.61%
View complete list of ENANTA PHARMACEUTICALS INC shareholders